Incyte (Nasdaq:INCY) today reported financial results for the third quarter of 2025 and provided a business update.
The winner of a 2025 SITC grant examines mechanisms that may help explain why drugs that work for some forms of lymphoma ...
Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback